Literature DB >> 16208885

Genetic testing and its implications: human genetics researchers grapple with ethical issues.

Isaac Rabino1.   

Abstract

To better understand ethical issues involved in the field of human genetics and promote debate within the scientific community, the author surveyed scientists who engage in human genetics research about the pros, cons, and ethical implications of genetic testing. This study contributes systematic data on attitudes of scientific experts. The survey finds respondents are highly supportive of voluntary testing and the right to know one's genetic heritage. The majority consider in utero testing and consequent pregnancy termination acceptable for cases involving likelihood of serious disease but disapprove for genetic reasons they consider arbitrary, leaving a gray area of distinguishing between treatment of disorders and enhancement still to be resolved. While safeguarding patient confidentiality versus protecting at-risk third parties (kin, reproductive partners) presents a dilemma, preserving privacy from misuse by institutional third parties (employers, insurers) garners strong consensus for legislation against discrimination. Finally, a call is made for greater genetic literacy.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Year:  2003        PMID: 16208885     DOI: 10.1177/0162243903028003002

Source DB:  PubMed          Journal:  Sci Technol Human Values        ISSN: 0162-2439


  3 in total

1.  Gene therapy: ethical issues.

Authors:  Isaac Rabino
Journal:  Theor Med Bioeth       Date:  2003

2.  The "how" and "whys" of research: life scientists' views of accountability.

Authors:  J M Ladd; M D Lappé; J B McCormick; A M Boyce; M K Cho
Journal:  J Med Ethics       Date:  2009-12       Impact factor: 2.903

3.  Consumers' intention to use health recommendation systems to receive personalized nutrition advice.

Authors:  Sonja Wendel; Benedict G C Dellaert; Amber Ronteltap; Hans C M van Trijp
Journal:  BMC Health Serv Res       Date:  2013-04-04       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.